ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Pneumonia
Human Influenza
Virus Diseases
Respiratory Tract Infections

COVID-19 trials near Salt Lake City, UT, USA:

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Active, not recruiting
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Salt Lake City, Utah, United States and 144 other locations

The purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5-...

Enrolling
COVID-19 Vaccines
Biological: BNT162b2

Phase 3

BioNTech
BioNTech

Salt Lake City, Utah, United States and 13 other locations

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

Phase 3

Pfizer
Pfizer

Clinton, Utah, United States of America and 262 other locations

The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to-...

Enrolling
COVID-19 Vaccines
Biological: BNT162b2 Vaccine
Biological: Tdap Vaccine

Phase 4

BioNTech
BioNTech

Salt Lake City, Utah, United States and 4 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Salt Lake City, Utah, United States and 74 other locations

the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

Phase 4

Moderna
Moderna

Salt Lake City, Utah, United States and 149 other locations

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Biological: Intramuscular vaccine
Drug: Intramuscular injection

Phase 2, Phase 3

Medicago

West Jordan, Utah, United States and 91 other locations

This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.

Enrolling
SARS-CoV-2
Biological: mRNA-1273
Biological: mRNA-1283

Phase 2

Moderna
Moderna

South Ogden, Utah, United States and 30 other locations

The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-8922...

Enrolling
Healthy Participants
Drug: S-892216-LAI
Drug: Placebo

Phase 1

Shionogi
Shionogi

Salt Lake City, Utah, United States and 2 other locations

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Tozorakimab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 465 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems